BioSpace News Archive

Drug Development

REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)

Early signs of neurocognitive stability in patient with previously diagnosed developmental delay; continued normal cognitive development in a younger patient

December 18, 2019
·
10 min read
Business

IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors..

December 18, 2019
·
3 min read
Business

DaVita Kidney Care Names New Chief Medical Officer

DaVita Kidney Care today announced Dr. Jeffrey Giullian as chief medical officer (CMO).

December 18, 2019
·
3 min read
Business

Community Oncology Alliance Elects Officers and New Board Members for 2020

The Community Oncology Alliance (COA) is pleased to announce the election of new and re-appointed members to the Board of Directors and Executive Committee.

December 18, 2019
·
4 min read
Business

BeyondSpring Provides Third-Quarter 2019 Operational and Financial Results Update

BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today provided an update on the Company’s operations and announced its financial results for the three months ended September 30, 2019.

December 18, 2019
·
16 min read
Business

LHC Group and Ochsner Health System announce acquisition expanding partnershipPartnership to acquire five additional locations

LHC Group, Inc. (NASDAQ: LHCG) and Ochsner Health System (Ochsner) announced an expansion of their joint venture partnership – Southeast Louisiana HomeCare – with an agreement to purchase five Egan Home Health and Hospice provider locations across South Louisiana.

December 18, 2019
·
5 min read
Business

GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) today announced that they have entered into a collaboration to discover, develop and commercialize novel therapies for sickle cell disease (SCD) and beta thalassemia.

December 18, 2019
·
7 min read
Business

IncellDx Signs Liquid Biopsy Distribution Agreement with Singapore-based Biolidics, Inc.

IncellDx, Inc. and Biolidics have announced that they have signed a Distribution Agreement for the IncellDx bioINK® PD-L1 CTC Core Kit. Biolidics will distribute the product with the Biolidics’ ClearCell® FX1 System.

December 18, 2019
·
1 min read
Biotech Bay

Cogitativo Raises $18.5M Series B round of financing

Cogitativo, Inc., the first-to-market data-science-as-a-service (DSaaS) company for healthcare service organizations, announced today the closing of an $18.5 million Series B round of financing.

December 18, 2019
·
4 min read
Business

Ribon Therapeutics Strengthens Scientific Advisory Board with Appointment of Neal Rosen, M.D., Ph.D.

Ribon Therapeutics, a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions, today announced the appointment of Neal Rosen, M.D., Ph.D., to its scientific advisory board (SAB).

December 18, 2019
·
5 min read